89 %In 2019, first-dose HPV vaccination coverage was estimated at 89% and second-dose coverage at 25% in Senegal.
Sénégalinfection à HPVobserved 2019HAL · Unilimdocument of 111 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
15 evidence items · page 1 / 1
47 %For the period 2022–2024, HPV first-dose vaccination coverage was assumed to be 47% and second-dose coverage 25% in Senegal.
Sénégalinfection à HPVobserved 2022–2024HAL · Unilimdocument of 111 observations
65 %In 2021, HPV vaccine first-dose coverage in Senegal was 65%.
Sénégalinfection à HPVobserved 2021HAL · Unilimdocument of 111 observations
47 %In 2020, HPV vaccine first-dose coverage in Senegal was 47%.
Sénégalinfection à HPVobserved 2020HAL · Unilimdocument of 111 observations
11,232 dosesThe school-based HPV vaccine demonstration project administered a total of 11,232 doses.
Sénégalinfection à HPVobserved 2014 to 2016HAL · Unilimdocument of 111 observations
31.75 %After rescaling to fit within a 100% envelope, the most prevalent HPV types in Senegal were type 16 (31.75%), type 18 (26.35%), type 45 (10.48%), and type 33 (9.84%).
Sénégalinfection à HPVHAL · Unilimdocument of 111 observations
47 %In 2020, first-dose HPV vaccination coverage declined to 47% and second-dose coverage to 32% in Senegal.
Sénégalinfection à HPVobserved 2020HAL · Unilimdocument of 111 observations
7 strategiesSeven HPV vaccination strategies were identified along the cost-effectiveness frontier.
Sénégalinfection à HPVHAL · Unilimdocument of 111 observations
25 %In 2019, only 25% of eligible girls in Senegal completed the second dose of HPV vaccine.
Sénégalinfection à HPVobserved 2019HAL · Unilimdocument of 111 observations
70 %In the base-case analysis, a single dose of the HPV vaccine was assumed to provide 70% to 100% of the total efficacy associated with two doses.
Sénégalinfection à HPVHAL · Unilimdocument of 111 observations
100 %The most common HPV types identified in a cervical cancer surveillance study in Senegal between 2013 and 2017 were type 16 (100%), type 18 (83%), and type 45 (33%).
Sénégalcancer du col de l'utérus · infection à HPVobserved 2013–2017HAL · Unilimdocument of 111 observations
32 %In 2020, HPV vaccine second-dose coverage in Senegal was 32%.
Sénégalinfection à HPVobserved 2020HAL · Unilimdocument of 111 observations
90 %The school-based HPV vaccine demonstration project in Dakar Ouest and Meckhe districts achieved 90% administrative coverage among nine-year-old girls.
Sénégalinfection à HPVobserved 2014 to 2016HAL · Unilimdocument of 111 observations
89 %In 2019, 89% of eligible girls in Senegal received the first dose of HPV vaccine.
Sénégalinfection à HPVobserved 2019HAL · Unilimdocument of 111 observations
80 %In the base-case analysis, a single dose of the HPV vaccine was assumed to provide 80% of the total efficacy associated with two doses.
Sénégalinfection à HPVHAL · Unilimdocument of 111 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.